Search Results

< Back 16th – 18th September, 2025 Philadelphia, PA 15th Advancing Women’s Leadership in Pharma & Healthcare Join a dynamic community dedicated to breaking barriers and advancing women’s leadership in pharma and healthcare. The 15th Advancing Women’s Leadership in Pharma & Healthcare Conference brings together senior leaders, rising executives, and change-makers committed to advancing women in leadership. This premier event explores strategies to build inclusive cultures, accelerate career progression, and strengthen leadership impact across the pharmaceutical and healthcare sectors. Through thought-provoking keynotes, real-world case studies, and peer-driven discussions, attendees will gain practical insights to lead with confidence, influence organizational change, and shape the future of healthcare. Previous Next

Collaboration with SRI demonstrates Nuvec®’s ability to selectively deliver RNA to cancer cells, advancing prospects for targeted, orally delivered RNA therapeutics. < Back N4 Pharma and SRI Advance Targeted RNA Delivery with Nuvec® Platform for Cancer Therapies Collaboration with SRI demonstrates Nuvec®’s ability to selectively deliver RNA to cancer cells, advancing prospects for targeted, orally delivered RNA therapeutics. N4 Pharma plc (AIM: N4P) has released new data from its collaboration with SRI International demonstrating the potential of its proprietary Nuvec® delivery platform to precisely target RNA payloads to cancer cells, a breakthrough that could reshape how RNA therapeutics are developed and delivered. The findings point to a future where common cancers such as lung, breast, and pancreatic could be treated with targeted RNA therapies, potentially in oral tablet form and with fewer side effects than conventional chemotherapy. The collaboration combined SRI’s targeting molecules with Nuvec® particles to deliver small interfering RNA (siRNA) payloads to non-small cell lung cancer cells. Results showed that Nuvec® functionalised with a targeting molecule binding to the αvβ6 adhesion protein, a marker overexpressed in many epithelial cancers, achieved precision delivery and selective uptake. siRNA payloads were active only when carried by targeted Nuvec® particles, confirming their ability to direct therapeutic action to diseased cells while sparing healthy tissue. “These recent data from our collaboration with SRI are particularly exciting because they represent the first example of the use of Nuvec® for the potential treatment of some of the most common and life-threatening cancers,” said Nigel Theobold, CEO of N4 Pharma. The results further validate Nuvec® as a differentiated RNA delivery system, supporting its broader application in oncology and beyond. Alongside its potential for targeted delivery, the platform offers multiple advantages including the ability to carry more than one RNA therapy in a single particle, stability suitable for oral delivery, low immunogenicity, and scalability in manufacturing. “Targeting RNA therapies to particular cell types is highly sought after by companies developing RNA therapeutics,” Theobold added. “We have now demonstrated Nuvec®'s ability to do this in multiple systems, which we believe sets it apart from other RNA delivery methods.” The global RNA therapeutics market, valued at $13.7 billion in 2023 and forecast to reach $18 billion by 2028, is growing rapidly but faces persistent challenges in manufacturing and delivery. Targeting specific tissues and reducing systemic toxicity remain among the biggest hurdles. Nuvec®’s latest data suggest it could help overcome these barriers and support deal-making with RNA therapy developers looking for next-generation delivery solutions. N4 Pharma raised capital earlier this year to generate data supporting Nuvec®’s key claims, including multi-RNA delivery, targeted uptake, oral dosing, and stability, with the aim of advancing both licensing opportunities and its own RNA therapeutics pipeline. Its lead program, N4 101, is an oral anti-inflammatory therapy for inflammatory bowel disease (IBD) designed to showcase the platform’s capabilities. Author BioFocus Newsroom Previous Next

< Back 26th – 27th February, 2025 Philadelphia, PA 9th Digital Strategy & Innovation for Medical Affairs Summit Prepare for the industry’s premier event about novel technologies and digital transformation among medical affairs teams. Discover ways to optimize digital innovation, work with regulatory and legal review partners, and explore data mining and knowledge retrieval using AI. Join us for the 8th Digital Strategy and Innovation for Medical Affairs conference, returning in 2025! Previous Next

< Back 23rd – 26th September, 2024 Boston, MA Biotech Week Boston Biotech Week Boston is a series of co-located events designed to connect scientists, technologists and vendors working across the whole spectrum of biopharmaceutical development and production. Be a part of this unique experience spanning the drug development value chain, giving you access to the most innovative scientific minds and business leaders in Boston and around the world. Previous Next

< Back 24th – 26th March, 2025 Boston, MA Immuno-Oncology 360º Build faster and more impactful collaborations with researchers, clinicians, biopharma leaders, investors and policymakers to advance cancer treatments. Hear directly from KOLs on the latest data to help advance and improve outcomes for more patients across a wider range of cancers. Stay ahead of the curve through 100+ multi-dimensional talks covering preclinical research, translational science, clinical development, operational strategies, cell therapy and business advancements. Previous Next

< Back 22nd – 23rd July, 2025 Boston, MA 5th Chief Patient Officer Summit The 5th Chief Patient Officer Summit is THE annual meeting place to share industry best practices and cutting-edge , innovative case studies in patient advocacy and engagement. This popular, “go to” event meaningfully connects peers who are building transparent, integral relationships with patient communities and cultivating a corporate culture dedicated to providing the best possible patient experience. In the heart of Boston, you will experience a community of fellowship and valuable content focused on listening and co-creating with patient communities and actionizing on patient feedback. Through best practice sharing and a deep exploration of timely topics, you’ll not only expand your valuable connections but emerge from the meeting ready for leadership and next steps to ensure the patient voice is heard and reflected in R&D, clinical and post approval. Previous Next

< Back 17th March, 2026 Philadelphia, PA Rare Disease Summit Accelerating innovation and commercial success in rare disease care. The Rare Disease Summit, taking place March 17–19, 2026 in Philadelphia, PA, brings together cross-functional leaders from biotech, pharma, payers, patient advocacy groups, and service partners to drive therapeutic innovation where medical need is greatest. This three-day event delivers actionable insights on launch planning, market access, reimbursement strategies, and strategic partnerships that shape successful rare disease commercialization. Through expert-led sessions, real-world case studies, and collaborative discussions, attendees will explore emerging trends, optimize value demonstration, and strengthen approaches to elevate patient impact across rare disease communities. Previous Next

< Back 4th – 7th May, 2025 Los Angeles, CA Milken Institute Global Conference The Milken Institute Global Conference brings together the world’s brightest minds to address the most urgent challenges and unlock the most promising opportunities of our time. This premier event connects individuals with the capital and influence to drive change with experts and innovators transforming health, finance, business, technology, philanthropy, industry, and society. In today’s complex world, we face escalating geopolitical tensions, an intensifying climate crisis, economic inequality, public health challenges, and the rapid advancement of artificial intelligence. These forces are reshaping industries, governance, and the global workforce. The 28th annual Global Conference will unite our diverse, forward-thinking community to tackle these critical issues and explore solutions that pave the way for a more sustainable, equitable, and resilient future. Join us to reflect on recent disruptions and innovations, and translate insights into meaningful actions to create healthy, prosperous lives for all. Previous Next

< Back 31st May – 4th June, 2024 Chicago, IL 2024 ASCO Annual Meeting The ASCO Annual Meeting is one of the most significant global events for bringing together oncology professionals. This year, it is hosted in Chicago, Illinois & Online. Previous Next

< Back 12th – 14th November, 2024 Boston, MA PMC Annual Personalized Medicine Conference The Annual Personalized Medicine Conference is designed to provide attendees with an opportunity to develop collaborative solutions to shared challenges in personalized medicine. Participants will exchange views with leading business executives, clinicians, journalists, and patient advocates in an intimate conference setting. Previous Next

< Back 27th – 28th October, 2025 Philadelphia, PA 4th Chief Commercial Officer Summit The 4th annual Chief Commercial Officer Summit highlights the vision and direction you need for driving commercial growth and excellence. Our all-new agenda helps you build the skills and business acumen to implement strategic, tactical and operational plans for advancing access and propelling commercial growth. This is a tremendous opportunity to join leading commercial executives and share information, insight and use cases! Join colleagues in Philadelphia in October 2025 and walk away with best practices for amplifying shareholder value, streamlining operations for peak efficiency and aligning core objectives with value retention and growth! Previous Next

< Back 18th – 20th March, 2025 Philadelphia, PA The Rare Disease Summit The Rare Disease Summit connects key stakeholders to drive therapeutic progress, propel commercial strategies and inspire impactful advocacy. You’ll generate solution-focused approaches surrounding patient access, reimbursement, commercialization, launch, partnering and more, as you unify in areas of unmet medical need. Previous Next